Kevin Lobo, Stryker CEO, weighs in on the company's quarterly results, and provides insight to company's bet on robotics.» Read More
Even with the overall stock market struggling to post gains, there are always winners somewhere. Carter Worth reveals where!
Jim Hardesty sees the glass more than half full. The strategist-economist of Hardesty Capital Management expects recovery -- and he has a few carefully-chosen stock picks.
Gabe Hilmoe is getting an early start on the stock market. He's portfolio manager of the Henry Fund at the University of Iowa, and he's got some strong ideas about equity investments.
Four-star fund manager Robert Millen thinks it's a good time for investors to be looking at quality growth companies. He admits that there may be some more darkness before the dawn.
Symmetry Medical proves investors can speculate and play defense at the same time.
To give investors an edge in this volatile market environment, CNBC asked the experts for their best trades now.
At a time of market uncertainty, what can an investor count on? Knee replacements, for one thing. Bruce Nudell, UBS senior research analyst, takes that as his cue in picking some promising stocks.
Cramer sounds off today with viewer calls on these topics: taking a slightly more bullish look at Stryker and Zimmer Holdings , both which may have been unfairly penalized by federal investigations that are behind them now; Merck being priced lower than its worth due to negative articles about Gardasil and in his opinion is still a definite Buy; knowing when to "ring the register" and take profits when you can without fearing taxes; and one more nice healthcare Buy: Masimo, a med tech company using innovative, non-invasive technology to monitor important health indicators, like blood oxygen, carbon monoxide and hemoglobin.
It's a booyah-free zone. There goes Swifty!
There are a lot of baby boomers out there and there's a lot of potential money to be made off of their retirement. Just be prepared to apply unconventional thinking to fit the habits of nontraditional people.
Overseas opportunities and recession proof consumer stocks were big in the stock chatter on CNBC Friday.
How does an investor get on the fast track in a slowing economy? Eric Schoenstein of Jensen Investment Management has a couple of suggestions.
Spring is finally in the air, and CNBC asked the experts how investors can best position their portfolios before the long weekend ahead.
What's the trade as a new breed of retirees begin their Miami migration?
Healthcare spending is expected to nearly double to $4.3 trillion by 2017. Who’s most likely to benefit and can you trade it?
Standard and Poor's has just released the results of its twice-a-year stock screen, designed to find Warren Buffett-style stocks. The new list features several tech stocks, including Apple, as well as a number of names from Europe and Asia. But some key Buffett criteria aren't taken into account by the screen.
Cramer makes the call on viewers' favorite stocks.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.
It's tough for a stock to get into Robert Millen's good graces. The co-portfolio manager of the Jensen Portfolio told CNBC he looks for companies with best-in-class products and steadily increasing bottom lines -- and he offered viewers two names that fit the bill.
Medical devices firm Smith & Nephew (S&N) posted a 16 percent rise in quarterly earnings on strong demand for a new hip implant, but its shares tumbled as an unchanged outlook disappointed investors.
What's on the minds of today's chief executives? Here's a sampling of what CEOs are saying on CNBC.